Stockreport

Elevation Oncology: Mid-2024 EO-3021 Data Could Get Ball Rolling [Seeking Alpha]

Elevation Oncology, Inc. - Common stock  (ELEV) 
PDF HER3-ADC is another ADC being developed in the pipeline for the treatment of patients with HER3-expressning solid tumors; It has been shown that up to 42% of tumors exp [Read more]